N/a
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-Intraday pattern: Runner
-Triple top at 27 which is important resistance on daily chart
-Levels: 22.50, 24, 25, 27.50
First Test long of 25 with whole dollar confluence
I was not expecting it to bounce from 25.50 which is why I only had a starter in this trade. Was going to size in closer to 25. Since I only had my starter lot I scaled out slowly 10 shares at a time, grabbing a better price each time.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-03-16 11:18:27 | MRNA | buy | $25.500 | long |
2020-03-16 11:26:51 | MRNA | sell | $25.990 | long |
2020-03-16 11:26:58 | MRNA | sell | $26.080 | long |
2020-03-16 11:27:21 | MRNA | sell | $26.160 | long |
2020-03-16 11:27:58 | MRNA | sell | $26.123 | long |
2020-03-16 11:28:02 | MRNA | sell | $26.220 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!